Giulia Perrone

4.1k citations

53 papers · 2.4k indexed · h-index 20

Impact in

Hematology top 0.5%
- Multiple Myeloma Research and Treatments
Oncology top 2%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Bone health and treatments

Papers in ⓘ

Hematology 38
- Multiple Myeloma Research and Treatments 35
- Hematopoietic Stem Cell Transplantation 5
Oncology 26
- Cancer Treatment and Pharmacology 10
- Bone health and treatments 5

Co-authors: Michèle Cavo (26 shared papers)Paola Tacchetti (24 shared papers)Michele Baccarani (25 shared papers)Elena Zamagni (24 shared papers)Patrizia Tosi (18 shared papers)Güllü Görgün (17 shared papers)Teru Hideshima (17 shared papers)Noopur Raje (11 shared papers)
Journals: Blood (29 papers)European Journal Of Haematology (3 papers)Biology of Blood and Marrow Transplantation (2 papers)Annals of Hematology (2 papers)Molecular Cancer Therapeutics (1 paper)
Partner nations: Italy United States Japan

In The Last Decade

Giulia Perrone

52 papers receiving 2.3k citations

Peers

Countries citing papers authored by Giulia Perrone

Since Specialization

Citations

This map shows the geographic impact of Giulia Perrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Perrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Perrone more than expected).

Fields of papers citing papers by Giulia Perrone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Perrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Perrone. The network helps show where Giulia Perrone may publish in the future.

Co-authors

The 25 scholars most cited alongside Giulia Perrone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Giulia Perrone Line = papers co-authored together Giulia Perrone links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation Blood ·Elena Zamagni, Francesca Patriarca, Cristina Nanni, Beatrice Anna Zannetti, Emanuela Englaro, Annalisa Pezzi, Paola Tacchetti, Silvia Buttignol, Giulia Perrone, Annamaria Brioli, Lucia Pantani, Carolina Terragna, Francesca Carobolante, Michele Baccarani, Renato Fanin, Stefano Fanti, Michèle Cavo	2011	355
2	Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma Blood ·Michèle Cavo, Elena Zamagni, Patrizia Tosi, Paola Tacchetti, Claudia Cellini, Delia Cangini, Antonio De Vivo, Nicoletta Testoni, Chiara Nicci, Carolina Terragna, Tiziana Grafone, Giulia Perrone, Michela Ceccolini, S Tura, Michele Baccarani	2005	258
3	A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma Haematologica ·Elena Zamagni, Cristina Nanni, Francesca Patriarca, Emanuela Englaro, P. Castellucci, Onelio Geatti, Patrizia Tosi, Paola Tacchetti, Delia Cangini, Giulia Perrone, Michela Ceccolini, Annamaria Brioli, Silvia Buttignol, R. Fanin, Eugenio Salizzoni, Michele Baccarani, Stefano Fanti, Michèle Cavo	2007	249
4	A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma Blood ·Güllü Görgün, Elisabetta Calabrese, Teru Hideshima, Jeffrey Ecsedy, Giulia Perrone, Mala Mani, Hiroshi Ikeda, Giada Bianchi, Yiguo Hu, Diana Cirstea, Loredana Santo, Yu‐Tzu Tai, Sabikun Nahar, Mei Zheng, Madhavi Bandi, Ruben D. Carrasco, Noopur Raje, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson	2010	232
5	Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma Blood ·Güllü Görgün, Elisabetta Calabrese, Ender Soydan, Teru Hideshima, Giulia Perrone, Madhavi Bandi, Diana Cirstea, Loredana Santo, Yiguo Hu, Yu‐Tzu Tai, Sabikun Nahar, Naoya Mimura, Claire Fabre, Noopur Raje, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson	2010	175
6	PI3K/p110δ is a novel therapeutic target in multiple myeloma Blood ·Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, Giulia Perrone, Naoya Miura, Hiroshi Yasui, Yutaka Okawa, Tanyel Kiziltepe, Loredana Santo, Sonia Vallet, Diana Cristea, Elisabetta Calabrese, Güllü Görgün, Noopur Raje, Paul G. Richardson, Nikhil C. Munshi, Brian J. Lannutti, Kamal D. Puri, Neill A. Giese, Kenneth C. Anderson	2010	156
7	Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound –Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma Molecular Cancer Therapeutics ·Diana Cirstea, Teru Hideshima, Scott J. Rodig, Loredana Santo, Samantha Pozzi, Sonia Vallet, Hiroshi Ikeda, Giulia Perrone, Güllü Görgün, Kishan Patel, Neil Desai, Peter Sportelli, Shweta Kapoor, Shireen Vali, Siddhartha Mukherjee, Nikhil C. Munshi, Kenneth C. Anderson, Noopur Raje	2010	136
8	AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition Oncogene ·Loredana Santo, Sonia Vallet, Teru Hideshima, Diana Cirstea, Hiroshi Ikeda, Samantha Pozzi, Kishan Patel, Yutaka Okawa, Güllü Görgün, Giulia Perrone, Elisabetta Calabrese, Murray Yule, Matthew Squires, Marco Ladetto, Mario Boccadoro, Paul G. Richardson, Nikhil C. Munshi, K C Anderson, Noopur Raje	2010	114
9	Ascorbic acid inhibits antitumor activity of bortezomib in vivo Leukemia ·Giulia Perrone, Teru Hideshima, Hiroshi Ikeda, Yutaka Okawa, Elisabetta Calabrese, Güllü Görgün, Loredana Santo, Diana Cirstea, Noopur Raje, Dharminder Chauhan, Michele Baccarani, Michèle Cavo, Kenneth C. Anderson	2009	79
10	Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma European Journal Of Haematology ·Patrizia Tosi, Elena Zamagni, Claudia Cellini, R. Plasmati, Delia Cangini, Paola Tacchetti, Giulia Perrone, Francesca Pastorelli, S Tura, Michele Baccarani, Michèle Cavo	2005	74
11	Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation Transplant Immunology ·Mario Arpinati, Gabriella Chirumbolo, Benedetta Urbini, Giulia Perrone, Damiano Rondelli, Claudio Anasetti	2003	54
12	The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM) Clinical Nuclear Medicine ·Cristina Nanni, Elena Zamagni, Monica Celli, Paola Caroli, Valentina Ambrosini, Paola Tacchetti, Annamaria Brioli, Beatrice Anna Zannetti, Annalisa Pezzi, Lucia Pantani, Giulia Perrone, Maurizio Zompatori, Michèle Cavo, Patrick M. Colletti, Domenico Rubello, Stefano Fanti	2012	51
13	Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma Oncotarget ·Enrica Borsi, Giulia Perrone, Carolina Terragna, Marina Martello, Angela Flores Dico, Giancarlo Solaini, Alessandra Baracca, Gianluca Sgarbi, Gianandrea Pasquinelli, Sabrina Valente, Elena Zamagni, Paola Tacchetti, Giovanni Martinelli, Michèle Cavo	2014	47
14	First‐line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma European Journal Of Haematology ·Patrizia Tosi, Elena Zamagni, Claudia Cellini, Raffaele Parente, Delia Cangini, Paola Tacchetti, Giulia Perrone, Michela Ceccolini, Paola Boni, S Tura, Michele Baccarani, Michèle Cavo	2006	42
15	Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation Biology of Blood and Marrow Transplantation ·Mario Arpinati, Gabriella Chirumbolo, Benedetta Urbini, Francesca Bonifazi, Giuseppe Bandini, Yogen Saunthararajah, Alessandra Zagnoli, Marta Stanzani, Sadia Falcioni, Giulia Perrone, S Tura, Michele Baccarani, Damiano Rondelli	2004	39
16	Short-Term Thalidomide Incorporated Into Double Autologous Stem-Cell Transplantation Improves Outcomes in Comparison With Double Autotransplantation for Multiple Myeloma Journal of Clinical Oncology ·Michèle Cavo, Francesco Di Raimondo, Elena Zamagni, Francesca Patriarca, Paola Tacchetti, Adriano Casulli, Silvestro Volpe, Giulia Perrone, A Ledda, Michela Ceccolini, Catello Califano, Catia Bigazzi, Massimo Offidani, Piero Maria Stefani, Filippo Ballerini, Mauro Fiacchini, Antonio De Vivo, Annamaria Brioli, Patrizia Tosi, Michele Baccarani	2009	34
17	Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency Biology of Blood and Marrow Transplantation ·Patrizia Tosi, Elena Zamagni, Paola Tacchetti, Michela Ceccolini, Giulia Perrone, Annamaria Brioli, Maria Caterina Pallotti, Lucia Pantani, Alessandro Petrucci, Michele Baccarani, Michèle Cavo	2010	26
18	Bisphosphonates and Osteonecrosis of the Jaws: Incidence in a Homogeneous Series of Patients with Newly Diagnosed Multiple Myeloma Treated with Zoledronic Acid. Blood ·Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Massimo Offidani, Sonia Ronconi, Giulia Perrone, Michela Ceccolini, Michele Baccarani, S Tura, Michèle Cavo	2005	25
19	HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment Experimental Cell Research ·Enrica Borsi, Giulia Perrone, Carolina Terragna, Marina Martello, Elena Zamagni, Paola Tacchetti, Lucia Pantani, Annamaria Brioli, Angela Flores Dico, Beatrice Anna Zannetti, Serena Rocchi, Michèle Cavo	2014	24
20	Superiority of Double over Single Autologous Stem Cell Transplantation as First-Line Therapy for Multiple Myeloma. Blood ·Michèle Cavo, Claudia Cellini, Elena Zamagni, Patrizia Tosi, Delia Cangini, Paola Tacchetti, Antonio De Vivo, Giulia Perrone, Roberto M. Lemoli, S Tura, Michele Baccarani	2004	19

About Giulia Perrone

Giulia Perrone is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Genetics, having authored 53 papers that have together received 2.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (35 papers), Protein Degradation and Inhibitors (13 papers), Cancer Treatment and Pharmacology (10 papers), Microtubule and mitosis dynamics (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Bone health and treatments (5 papers), Immunotherapy and Immune Responses (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Hematology (1.5k citations), Oncology (1.2k citations), Genetics (248 citations), Molecular Biology (1.3k citations) and Immunology (267 citations). Giulia Perrone has collaborated with scholars based in Italy, United States and Japan. Frequent co-authors include Michèle Cavo, Paola Tacchetti, Michele Baccarani, Elena Zamagni, Patrizia Tosi, Güllü Görgün, Teru Hideshima, Noopur Raje, Delia Cangini and Annamaria Brioli. Their work appears in journals such as Blood, European Journal Of Haematology, Biology of Blood and Marrow Transplantation, Annals of Hematology and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact